MT Group Blog

Filter

Serum vs. Plasma for Biomarker Research: A Procurement Decision Framework for R&D and Sourcing Teams

April 29, 2026
Serum and plasma are both derived from whole blood, and both are widely used in…

Matched Healthy Controls in Translational Research: The Selection Criteria That Determine Study Validity

April 20, 2026
Healthy controls are among the most underspecified elements in translational biomarker study design. Researchers invest…

Sourcing cfDNA, ctDNA, and CTCs: A Procurement Guide for Liquid Biopsy Research Teams

April 10, 2026
Liquid biopsy has reshaped how researchers and clinicians think about tumor biology, treatment monitoring, and…

The Hidden Challenge in Assay Development: Why Pre-Analytical Variables Can Make or Break Your Assay

September 3, 2025
Assay developers invest millions of dollars perfecting their analytical methodologies, optimizing primer sequences, refining detection…

Essential Factors for Successful Biospecimen Collection

August 12, 2025
When it comes to biospecimen collection, attention to detail can make the difference between reliable…

Clinical Biospecimens For Research

February 14, 2025
Revolutionizing Research with High-Quality Clinical Biospecimens Welcome to MT Group, where cutting-edge science meets a…

MT Group Autoimmune & Inflammatory Disease Biospecimen Program

July 8, 2024
The MT Group is pleased to announce its Autoimmune & Inflammatory Disease Biospecimen Program, which…

Small Cell Lung Cancer Tissue

July 8, 2024
MT Group's boutique biobank now includes FFPE collected from subjects with small cell lung cancer…

Matched Biospecimens from Cancer Subjects for Translational Research

July 14, 2023
Are you in need of matched biospecimens from cancer subjects? The MT Group has diligently…